Molecular Mechanisms and Therapeutic Strategies for
Retinal Degeneration

Xinhua      Shu; Ling      Zhu

[1] 
Wright, A.F.; Chakarova, C.F.; El-Aziz, A.; Mai, M.; Bhattacharya, S.S. Photoreceptor degeneration: genetic and mechanistic dissection of a complex trait. Nat. Rev. Genet.,  2010, 11(4), 273-284.
[2] 
Zou, T.; Wang, T.; Zhen, F.; He, X.; Dong, S.; Zhang, H. Exogenous PDE5 Expression Rescues Photoreceptors in RD1 Mice. Curr. Med. Chem.,  2022, 29(40), 6115-6124.
[3] 
Wu, X.; Yan, N.; Zhang, M. Retinal Degeneration: Molecular Mechanisms and Therapeutic Strategies. Curr. Med. Chem.,  2022, 29(40), 6125-6140.
[4] 
Cao, Y.; Li, Y.; Gkerdi, A.; Reilly, J.; Tan, Z.; Shu, X. Association of nutrients, specific dietary patterns, and probiotics with age-related macular degeneration. Curr. Med. Chem.,  2022, 29(40), 6141-6158.
[5] 
Wong, W.L.; Su, X.; Li, X.; Cheung, C.M.G.; Klein, R.; Cheng, C.Y.; Wong, T.Y. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob. Health,  2014, 2(2), e106-e116.

Download Options

Rights & Permissions Print Cite

Current Medicinal Chemistry

Title:Molecular Mechanisms and Therapeutic Strategies for Retinal Degeneration

Volume: 29 Issue: 40

Author(s): Xinhua Shu and Ling Zhu

Affiliation:

Export Options

Export File:

RIS (for EndNote, Reference Manager, ProCite)

BibTeX

Text

Content:

Citation Only

Citation and Abstract

About this article

Cite this article as:

Shu Xinhua and Zhu Ling, Molecular Mechanisms and Therapeutic Strategies for Retinal Degeneration, Current Medicinal Chemistry 2022; 29 (40) . https://dx.doi.org/10.2174/092986732940220920153619

DOI https://dx.doi.org/10.2174/092986732940220920153619	Print ISSN 0929-8673
Publisher Name Bentham Science Publisher	Online ISSN 1875-533X

About this journal

Call for Papers in Thematic Issues

Submission closes on : 08 September, 2024

Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.

The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more

Guest Editor(s): Geir Bj?rklund

Submission closes on : 08 July, 2024

Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications

The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more

Guest Editor(s): Igor A. Sobenin

Submission closes on : 14 July, 2024

Chalcogen-modified nucleic acid analogues

Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more

Guest Editor(s): Katarzyna Kulik

Submission closes on : 03 June, 2024

Current advances in inherited cardiomyopathy

Describe in detail all novel advances in multimodality imaging related to inherited cardiomyopathy diagnosis and prognosis. Shed light to deeper phenotypic characterization. Acknowledge recent advances in genetics, genomics and precision medicineread more

Guest Editor(s): Emmanuel S. Androulakis